Clinical Trial: A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC).

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483489) titled 'A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC).' on March 16.

Brief Summary: This is a randomized, multicenter, double-blind, placebo-controlled, parallel-designed phase 2 clinical trial to evaluate the efficacy, safety and pharmacokinetic (PK) characteristics of HW091077 in Chinese adult subjects with refractory chronic cough or unexplained chronic cough (RCC/UCC).

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Refractory Chronic Cough

Intervention: DRUG: HW091077

HW091077 oral tablet, oral, QD

DRUG: HW091077

HW091077 oral tablet, oral, QD ...